BOVELA, a BVD vaccine, has taken the leading spot in terms of share of sales per month during July for the first time since its launch in March 2015.

More than five million doses of Bovela have now been sold across Europe, highlighting just how quickly farmers have understood the benefits of a single dose vaccine that provides a full 12 months of live vaccine protection.

Mart Yarnall of manufacturers, Boehringer Ingelheim said, "This is fantastic news for Bovela which offers a truly unique and innovative way of controlling BVD in a herd, something that is now clearly being appreciated by farmers and vets alike."

He concluded: "Feedback we have from vets and farmers throughout Europe shows two main things. Firstly, for those who haven’t controlled BVD before, there is the realisation of how much better herd health can be and secondly, for those who have previously struggled with multiple primary course vaccines or those that should be boosted every six months, there is relief at Bovela’s easy-to-follow regime."